Cart summary

You have no items in your shopping cart.

Uzansertib phosphate

SKU: orb1309243

Description

Uzansertib phosphate (INCB053914 phosphate) is an orally bioavailable, ATP-competitive pan-PIM kinase inhibitor, demonstrating potent activity against PIM1, PIM2, and PIM3. It is a research tool used in vitro and in vivo to study oncology, hematological malignancies, and signaling pathways involving PIM kinases.

Research Area

Epigenetics & Chromatin, Signal Transduction

Images & Validation

Key Properties

CAS Number2088852-47-3
MW611.51
Purity99.85% (May vary between batches)
FormulaC26H29F3N5O7P
SMILESO=C(C1=NC(C2=C(F)C=CC=C2F)=C(F)C=C1)NC3=CN=C4C(CC[C@H]4O)=C3N5C[C@@H](N)[C@H](O)[C@@H](C)C5.O=P(O)(O)O
TargetPim
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.64 mM);DMSO:5 mg/mL (8.18 mM)

Bioactivity

Target IC50
Pim2:30 nM|Pim3:0.12 nM|Pim1:0.24 nM
In Vivo
Effects were confirmed in primary bone marrow blasts from patients with acute myeloid leukemia treated ex vivo and in blood samples from patients receiving INCB053914 in an ongoing phase 1 dose-escalation study. In vivo, single-agent INCB053914 inhibited Bcl-2-associated death promoter protein phosphorylation and dose-dependently inhibited tumor growth in acute myeloid leukemia and multiple myeloma xenografts. Additive or synergistic inhibition of tumor growth was observed when INCB053914 was combined with selective PI3Kδ inhibition, selective JAK1 or JAK1/2 inhibition, or cytarabine.
In Vitro
INCB053914, a novel, potent, and selective adenosine triphosphate-competitive pan-PIM kinase inhibitor. In vitro, INCB053914 inhibited proliferation and the phosphorylation of downstream substrates in cell lines from multiple hematologic malignancies.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Pim, Pim kinases, PIM3, PIM2, PIM1, Uzansertib, Uzansertib Phosphate, Uzansertib phosphate, tumor, lines, inhibit, INCB 053914, INCB 053914 Phosphate, INCB053914 phosphate, INCB053914 Phosphate, INCB-053914 Phosphate, INCB053914, INCB-053914, orally, Inhibitor, hematologic, malignancies, cell, activity, ATP-competitive, anti-proliferative, broad

Similar Products

  • INCB053914 phosphate [orb1218480]

    >98% (HPLC)

    2088852-47-3

    611.51

    C26H29F3N5O7P

    10 mg, 1 g, 500 mg, 200 mg, 5 mg, 25 mg, 50 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Uzansertib phosphate (orb1309243)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 mg
$ 130.00
5 mg
$ 270.00
10 mg
$ 390.00
25 mg
$ 670.00
50 mg
$ 920.00
100 mg
$ 1,260.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry